NASDAQ:COLL

Collegium Pharmaceutical Stock Insider Trading

etoro logo Buy COLL
*Your capital is at risk
$31.06
+0.580 (+1.90%)
At Close: Jun 03, 2026

Collegium Pharmaceutical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -64.76. In total, the insiders bought 860.21K and sold 468.05K COLL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-64.76
Buy 860.21K shares
Sell 468.05K shares
62% Buy Activity
Weak Negative Correlation
Sell Signal Medium Confidence
Mar 03, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -64.76.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Aug 07, 2025
Buy
Common stock, par value $0.001 per share
Rubric Capital Management Lp
10 Percent Owner
10% Owner 0
Value: $0
Aug 07, 2025
Buy
Common stock, par value $0.001 per share
Rubric Capital Management Lp
10 Percent Owner
10% Owner 0
Value: $0
Jun 09, 2025
Buy
Common Stock
M-Exempt
Freund John Gordon
Director
Director 15 000
Value: $201.8K
Jun 09, 2025
Sell
Common Stock
S-Sale
Freund John Gordon
Director
Director 6 601
Value: $202.1K
Jun 09, 2025
Buy
Stock Option (Right to Purchase)
M-Exempt
Freund John Gordon
Director
Director 15 000
Value: $201.8K
Jun 09, 2025
Buy
Stock Option (Right to Purchase)
M-Exempt
Freund John Gordon
Director
Director 15 000
Value: $201.8K
Jun 09, 2025
Sell
Common Stock
S-Sale
Freund John Gordon
Director
Director 6 601
Value: $202.1K
Jun 09, 2025
Buy
Common Stock
M-Exempt
Freund John Gordon
Director
Director 15 000
Value: $201.8K
May 15, 2025
Buy
Common Stock
A-Award
Fallon John A.
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Lurker Nancy
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Bohlin Garen G
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Balice-gordon Rita J.
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Freund John Gordon
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Santini Gino
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Paya Carlos V
Director
Director 19 582
Value: $574.5K
May 15, 2025
Buy
Common Stock
J-Other
Paya Carlos V
Director 0
Value: $0
May 15, 2025
Buy
Common Stock
J-Other
Paya Carlos V
Director 0
Value: $0
May 15, 2025
Buy
Common Stock
A-Award
Paya Carlos V
Director
Director 19 582
Value: $574.5K
May 15, 2025
Buy
Common Stock
A-Award
Santini Gino
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Freund John Gordon
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Balice-gordon Rita J.
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Bohlin Garen G
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Lurker Nancy
Director
Director 9 791
Value: $287.3K
May 15, 2025
Buy
Common Stock
A-Award
Fallon John A.
Director
Director 9 791
Value: $287.3K
Mar 21, 2025
Sell
Common Stock
S-Sale
Tupper Colleen
EVP & Chief Financial Officer
C-Suite Officer 6 396
Value: $192.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT COLLEGIUM PHARMACEUTICAL
Collegium Pharmaceutical
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE